Australian Medical Association Pushes Legislation Against E-cigarette Behavior

Regulations by 2FIRSTS.ai
May.27.2024
Australian Medical Association Pushes Legislation Against E-cigarette Behavior
Australia Medical Association pushes for legislation to combat e-cigarette use, facing opposition within government parties. Vote to take place in June.

According to The Guardian on May 26th, the Australian Medical Association is pushing for parliament in Canberra to pass legislation to combat e-cigarette use. The bill is expected to be voted on in June. The ban proposed by the Australian Labor Party on the import and commercial ownership of e-cigarettes is facing obstacles.

 

According to reports, the Australian National Party is hoping to legislate similar restrictions on e-cigarette behavior as tobacco, without the need for a prescription, while also enforcing the same regulations on packaging and taxes. The Australian Liberal Party sometimes allows its smaller coalition partners to dictate the course, and Peter Dutton has expressed dissatisfaction with the ban. However, the party's Minister for Market Education, Sarah Henderson, and others have publicly criticized e-cigarette behavior, describing it as a "menace" in schools.

 

Overall, crossing party lines and working with the Greens is often the safest route in the Senate. In May of this year, the Greens' health spokesperson Jordon Steele-John agreed with a recent survey report that the bill should be passed. However, he cautioned in other comments that the Greens do not "support banning e-cigarettes for adults."

 

This may include revising laws to ensure that individuals are not criminalized for possession, providing adequate support for smoking cessation, and restricting advertising of e-cigarettes to doctors. The party will decide on its stance in the next two weeks.

 

According to reports, the President of the Australian Medical Association, Steve Robson, has given a direct message to lawmakers who "seem more willing to listen to tobacco lobbying groups and political donors than to parents, health departments, and children." He stated, "We hope to encourage the opposition party and others to do the right thing, not listen to donors, and protect Australia's children from the dangers of e-cigarettes.

 

He expressed being "shocked" and "disappointed" to reporters in Canberra, as the National Party is seeking to tax e-cigarettes instead of banning non-prescription e-cigarettes. He also posed serious questions to the Greens party.

 

He believes, "The Green Party is a political party that places the future of the next generation at the core of its policies, which is obviously something they should support, if they truly prioritize the health and well-being of children.

 

Robson asked Health Minister Mark Butler if the regulation of e-cigarettes is stricter than tobacco, despite the latter being more harmful. In order to prevent this situation, is it possible that restrictions on tobacco based on birth year, similar to what New Zealand has attempted, may be implemented.

 

Butler said at the National Press Club conference in May 2023 that the difference is that "tobacco has been with us for too long," while e-cigarettes are still "relatively new." He said, "If we knew then what we know now about the introduction of tobacco, I hope the government would have taken immediate action, just as I now want to tackle e-cigarettes. We have an opportunity now, with e-cigarettes becoming so widespread, accepted, and normalized...to seize this moment before taking any action becomes extremely difficult.

 

Everyone agrees that children should not use e-cigarettes, but that does not mean burdening legislation with the most stringent possible methods. If the goal is not to criminalize a particular group of individuals, then the relevant laws should be revised to ensure that this does not happen. If we had known the current situation when introducing tobacco, the government may have immediately banned tobacco, just as it is now aiming to address e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy Proposes Earlier Vape and HTP Tax Hikes, New Rules for E-Liquid Pricing, Exclusive Deals and Distribution
Italy's proposed 2027–2029 budget would bring forward scheduled tax increases for e-cigarette liquids and heated tobacco products from January 1, 2028, to July 1, 2027. The consumption tax coefficient for nicotine-containing e-liquids would rise from 20% to 22%, that for nicotine-free liquids and applicable flavorings from 15% to 17%, and the heated-tobacco coefficient from 41% to 42%. The bill would also introduce official retail price schedules for e-liquids, restrict exclusive agreements between retailers and suppliers, and limit single-brand-dominated displays, sales incentives and bundled offers. Importing, authorized warehousing and retailer sourcing arrangements would also change. The proposals remain subject to parliamentary approval and subsequent implementing regulations.
Regulations
Nov.04
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives